Jasper Therapeutics climbs ahead of Oppenheimer summit

Oct. 15, 2021 10:46 AM ETJasper Therapeutics, Inc. (JSPR)By: Dulan Lokuwithana, SA News Editor1 Comment

Success business chart with green arrow up and USA dollars background. Profit and money. Financial and business graph. Stock market growth 3d illustration.

JuSun/iStock via Getty Images

  • Jasper Therapeutics (JSPR +21.6%) has added over a fifth of value to its market cap in morning hours ahead of an Oppenheimer summit scheduled for today. More than 16M shares have changed hands

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.